Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Apr 30:10:263.
doi: 10.3389/fendo.2019.00263. eCollection 2019.

Roles of Type 1 Insulin-Like Growth Factor (IGF) Receptor and IGF-II in Growth Regulation: Evidence From a Patient Carrying Both an 11p Paternal Duplication and 15q Deletion

Affiliations
Case Reports

Roles of Type 1 Insulin-Like Growth Factor (IGF) Receptor and IGF-II in Growth Regulation: Evidence From a Patient Carrying Both an 11p Paternal Duplication and 15q Deletion

Eloïse Giabicani et al. Front Endocrinol (Lausanne). .

Abstract

We report an original association of complex genetic defects in a patient carrying both an 11p paternal duplication, resulting in the double expression of insulin-like growth factor 2 (IGF2), as reported in Beckwith-Wiedemann syndrome, and a 15q terminal deletion, including the type 1 IGF receptor gene (IGF1R), resulting in haploinsufficiency for this gene. The patient was born with measurements appropriate for her gestational age but experienced growth retardation in early childhood, allowing a better comprehension of the IGF system in the pathophysiology of growth. It is possible that IGF-II plays a key role in fetal growth, independently of IGF1R signaling, and that its role is less important in post-natal growth, leaving IGF-I and growth hormone as the main actors.

Keywords: 11p duplication; Beckwith-Wiedemann syndrome; IGF-II; IGF1 receptor; fetal growth restriction; imprinting disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of 11p15 region gene expression.
Figure 2
Figure 2
Growth curve of the patient in centimeters and standard deviation score (SDS).
Figure 3
Figure 3
(A) Paired homologous chromosomes15 with Derivative chromosome 15 (left couple, on the right) and apparently normal 15 G-banded chromosomes 15 (middle couple) and (right couple). The two apparently normal chromosomes were then shown to carry a 15q terminal deletion (middle couple, on the right) and be a derivative chromosome 11 (right couple, on the right). (B) The SNP array profile shows a normal chromosome 21 (top), a heterozygous homogeneous 15q terminal deletion (middle, light purple area), and a mosaic gain on chromosome 11p (bottom, light purple area). (C) FISH [with a specific 11p subtelomeric probe (green), specific 15q22 probe (aqua blue), specific 15q subtelomeric probe (yellow), and specific subtelomeric 21q probe (red)] and schematic representation showing chromosomes 11, 15, and 21 in the three cell lines. First cell line with an unbalanced 15q;21p translocation. (D) Second cell line with a deleted 15q chromosome. The derivative chromosome 15 is missing a yellow signal. (E) Third cell line with an unbalanced 11p;15q translocation. The derivative chromosome 15 has a supernumerary green signal and no yellow signal.

References

    1. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev. (1995) 16:143–63. - PubMed
    1. Eggermann T, Perez de Nanclares G, Maher ER, Temple IK, Tümer Z, Monk D, et al. . Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci. Clin Epigenetics. (2015) 7:123. 10.1186/s13148-015-0143-8 - DOI - PMC - PubMed
    1. Rotwein P. Large-scale analysis of variation in the insulin-like growth factor family in humans reveals rare disease links and common polymorphisms. J Biol Chem. (2017) 292:9252–61. 10.1074/jbc.M117.783639 - DOI - PMC - PubMed
    1. Baran Y, Subramaniam M, Biton A, Tukiainen T, Tsang EK, Rivas MA, et al. . The landscape of genomic imprinting across diverse adult human tissues. Genome Res. (2015) 25:927–36. 10.1101/gr.192278.115 - DOI - PMC - PubMed
    1. Brioude F, Kalish JM, Mussa A, Foster AC, Bliek J, Ferrero GB, et al. . Expert consensus document: clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement. Nat Rev Endocrinol. (2018) 14:229–49. 10.1038/nrendo.2017.166 - DOI - PMC - PubMed

Publication types